Masuda, Daisaku

Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases

Yamashita, S., Masuda, D., & Matsuzawa, Y. (2020) · Current Atherosclerosis Reports

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 191

Postprandial Hyperlipidemia and Remnant Lipoproteins

Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 145

Impaired Insulin Secretion in Four Tangier Disease Patients with ABCA1 Mutations

Koseki, M., Matsuyama, A., Nakatani, K., Inagaki, M., Nakaoka, H., Kawase, R., Yuasa-Kawase, M., Tsubakio-Yamamoto, K., Masuda, D., C. Sandoval, J., et al. (2009) · Journal of Atherosclerosis and Thrombosis

Pancreatic function and diabetesLipid metabolism and disorders

Cited by 65

Accelerated Atherogenicity in Tangier Disease: A Case Accompanied by Extensive Atherosclerotic Lesions, Leriche Syndrome and Bleeding Tendency, and Review of the Literature

Muratsu, J., Koseki, M., Masuda, D., Yasuga, Y., Tomoyama, S., Ataka, K., Yagi, Y., Nakagawa, A., Hamada, H., Fujita, S., et al. (2018) · Journal of Atherosclerosis and Thrombosis

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 27

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate

Yamashita, S., Okazaki, M., Okada, T., Masuda, D., Yokote, K., Arai, H., Araki, E., & Ishibashi, S. (2021) · Journal of Atherosclerosis and Thrombosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 14

Effects of Selective PPARα Modulator K-877 on Particle Numbers of Lipoprotein Subclasses in Dyslipidemic Patients: Analysis by GP-HPLC and NMR Lipoprofile 2 and 3

Yamashita, S., Okazaki, M., Okada, T., Masuda, D., Arai, H., Yokote, K., Araki, E., & Ishibashi, S. (2018) · Atherosclerosis Supplements

Lipoproteins and Cardiovascular HealthPeroxisome Proliferator-Activated Receptors

Cited by 2